AVBP
ArriVent BioPharma, Inc. Common Stock
NASDAQ: AVBP · HEALTHCARE · BIOTECHNOLOGY
$31.09
+3.46% today
Updated 2026-04-30
Market cap
$1.34B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.32
Dividend yield
—
52W range
$16 – $32
Volume
0.5M
ArriVent BioPharma, Inc. Common Stock (AVBP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-58.90%
ROA
-36.50%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | — | $-51.61M | — | — | — |
| 2022 | $0.00 | $-36.91M | — | — | — |
| 2023 | $0.00 | $-69.33M | — | — | — |
| 2024 | $0.00 | $-80.49M | — | — | — |
| 2025 | $0.00 | $-166.31M | — | — | — |